5 EASY FACTS ABOUT IS ABBV-744 EFFECTIVE FOR HEMATOLOGIC CANCERS? DESCRIBED

In Phase C, individuals will receive ABBV-744 and oral navitoclax. In Segment D, members will receive ABBV-744 and ruxolitinib. Individuals will receive treatment right up until illness progression or maybe the participants are not able to tolerate the study drugs.- "Our study unveiled the critical position from the KLF16/MYC regulatory axis in mod